Gastroenterology Clinical Research Trends
What is this
This trend highlights active clinical research in gastroenterology, emphasizing improved screening techniques and innovative nutritional and surgical interventions. It aggregates signals from studies on colorectal cancer screening, precision-based trials, and critical care nutrition.
Why it matters
Gastroenterology remains a high-burden medical field, with colorectal cancer being one of the leading causes of cancer mortality. Increasing healthcare focus on early detection, personalized nutrition, and minimally invasive procedures creates a pressing need for improved practices.
Investment angle
Investors can target companies developing advanced endoscopic devices, diagnostic imaging technologies, and novel therapeutic interventions in the gastrointestinal space. Opportunities also exist in biotech firms and digital health startups that support clinical trials and data analytics for gastroenterology.
A promising clinical research trend with significant market demand and growth potential, balanced by inherent clinical risks; investability: 7/10.
History
| date | signals | new | substance |
|---|---|---|---|
| 2026-03-13 | 4 | 100% | |
| 2026-03-25 | 8 | +4 | 100% |
| 2026-04-06 | 9 | +1 | 100% |
| 2026-04-18 | 10 | +1 | 100% |
| 2026-04-29 | 18 | +8 | 94% |
| 2026-05-11 | 21 | +3 | 95% |
| 2026-05-24 | 24 | +3 | 96% |
| 2026-06-05 | 25 | +1 | 96% |
| 2026-06-16 | 28 | +3 | 96% |
| 2026-06-28 | 28 | +0 | 96% |
| 2026-07-09 | 31 | +3 | 97% |
| 2026-07-21 | 34 | +3 | 97% |
| 2026-08-01 | 37 | +3 | 97% |
| 2026-08-13 | 43 | +6 | 98% |
Evidence
- 2026-08-12ClinicalTrials.gov[] Plasma GLP-2 Dynamics and Acute Radiation Enteritis After Abdominopelvic Radiotherapy · detail
- 2026-08-09NIH RePORTERControl of Inflammatory Acidity in Mucosal Inflammation · detail
- 2026-08-08PubMedGastrointestinal digestion characteristics and bioactive peptide production of tsampa proteins. · detail
- 2026-08-06ClinicalTrials.gov[EARLY_PHASE1] The MIMIGA Study is a Randomized, Double-blind, Placebo-controlled Crossover Trial Evaluating the Safety and Efficacy of SCFA vs. Placebo. Administered Orally Once Daily With Standard Care, it Aims to Prevent CKD Progression in Biopsy-proven IgA Nephropathy by Modulating the Gut Microbiome. · detail
- 2026-08-04ClinicalTrials.gov[NA] A Pilot Study Evaluating the Impact of a Prebiotic Soda on Gastrointestinal Symptoms in Users of GLP-1 Agonists · detail
- 2026-08-03ClinicalTrials.gov[PHASE3] A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF) · detail
- 2026-07-30ClinicalTrials.gov[NA] Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy: A Randomized Controlled Trial in Taiwan. · detail
- 2026-07-30ClinicalTrials.gov[PHASE3] Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy. · detail
- 2026-07-26PubMed[Irritable bowel syndrome: an organic disease]. · detail
- 2026-07-18PubMedRecent developments in the therapeutic management of acid-related gastrointestinal diseases. · detail
- 2026-07-15ClinicalTrials.gov[PHASE2] A Clinical Study of FT1 in Patients With Short Bowel Syndrome · detail
- 2026-07-12NIH RePORTEREfficacy and Safety of Proteolytic Activity-Guided fecal Microbiota Transplantation for Irritable Bowel Syndrome (PRAGMAT trial) · detail
- 2026-07-07ClinicalTrials.gov[NA] The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals · detail
- 2026-06-29ClinicalTrials.gov[NA] Dietary Macronutrients and Gut Microbiota, Inflammation, and Metabolic Markers · detail
- 2026-06-29ClinicalTrials.gov[] Gastrointestinal Hormones and Metabolomic Profiling Following Mixed-Meal Tolerance Tests in Patients at Risk of Refeeding Syndrome · detail
- 2026-06-11OpenAlexFarmacometrische benaderingen voor therapie-individualisering bij patiënten met gastrointestinale aandoeningen · detail
- 2026-06-08OpenAlexTranslational Gastroenterology and Hepatology · detail
- 2026-06-05ClinicalTrials.gov[] GLP-1 RA Cessation and Gastric Ultrasound Findings · detail
- 2026-05-29OpenAlexEnfermedad inflamatoria intestinal: últimos avances relacionados con la microbiota · detail
- 2026-05-22OpenAlexAnalysis of intestinal failure-associated liver disease in patients receiving home parenteral support · detail